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(57) ABSTRACT 
Apparatus and method for early detection of cystic struc- 
tures indicative of ovarian and breast cancers uses ultrasonic 
wave energy at a unique resonance frequency for inducing 
cavitation in cystic fluid characteristic of cystic structures in 
the ovaries associated with ovarian cancer, and in cystic 
structures in the breast associated with breast cancer. 
Induced cavitation bubbles in the cystic fluid implode, 
creating implosion waves which are detected by ultrasonic 
receiving transducers attached to the abdomen of the patient. 
Triangulation of the ultrasonic receiving transducers enables 
the received signals to be processed and analyzed to identify 
the location and structure of the cyst. 
14 Claims, 3 Drawing Sheets 
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DETECTION OF CYSTIC STRUCTURES 
USING PULSED ULTRASONICALLY 
INDUCED RESONANT CAVITATION 
CROSS REFERENCE TO RELATED 
APPLI CAT1 ON 
significant time by a radiologist, and concluded that auto- 
mated ultrasonography devices are needed, if only to evalu- 
ate the usefulness of ultrasonography in improving breast 
cancer detection. 
The present invention provides such a device, with novel 
ultrasonography features making the method rapid, accurate, 
reproducible and capable of automation. The device can be 
constructed so as to be able to compare standard ultrasonog- 
raphy images with selective induction of ultrasonic cavita- 
tion (SINUC) generated images and distinguish cystic from 
non-cystic structures. 
There has yet to be clinically identified any pre-malignant 
condition which would presage the onset of ovarian cancer. 
Because most ovarian cancers are cystic in nature, the 
1s recognition of an irregular, septate, fluid-filled lesion in the 
ovary has been the focus of detection by the medical 
community. Various imaging technologies, including 
p o s i t r o n  e m i s s i o n  t o m o g r a p h y  ( P E T ) ,  
radioimmunoscintography, magnetic resonance imaging 
scanning, and 
ultrasonography, all are capable of detecting cystic struc- 
tures in the ovary. 
The recent addition of color flow Doppler imaging in 
combination with transvaginal sonography appears to have 
2s added another level of sensitivity to the detection of ovarian 2. Description of Background Art 
Breast cancer is the most common cancer and the second abnormalities, Cohen and jennings (h J Obstet, ~ ~ ~ ~ ~ l ;  
most common cause of cancer-related death in women, with 170:1088-1094) report that endovaginal probes at frequen- 
175,000 cases and 43,700 deaths projected in 1999 in the cies of 6.5 to 7.5 MHZ provide much finer discrimination of 
United States. Ovarian cancer is the fourth leading cause of the ovary and uterus than is achievable with transabdominal 
cancer-related death among females in the United States, 30 ultrasonography. However, the use of various antigen 
with over 25,000 new cases in 1998 and approximately half markers, in particular Ca 125, in combination with transab- 
that number in deaths. When diagnosed at an early stage, dominal and transvaginal sonography, or (in one study) 
there is a very high likelihood of cure for both diseases; magnetic resonance imaging, has failed to achieve the levels 
however, because of the location and usually asymptomatic of sensitivity and specificity necessary for a highly reliable 
nature of even relatively advanced ovarian cancer, this type 3s screening technique, 
of cancer exhibits a high morbidity and mortality rate. sensitive, specific, and 
Moreover, current methods of breast screening with physical affordable technique for early detection of ovarian and 
examination and mammography still miss a significant num- breast cancers, 
ber of breast cancers detectable by ultrasonography. 
SUMMARY OF THE INVENTION 
make precise characterization and accurate follow-up by The present invention provides a solution to the existing 
physical examination and mammography problematic. The need in the art by providing a noninvasive technique for the 
complex nature of the fibrocystic breast in premenopausal early detection of cystic structures using ultrasonic waves, 
women is a particular challenge to the diagnostician, which potentially at the levels of microns. The present invention is 
should be especially amenable to characterization by the 45 based on the fact that most ovarian cancers and many breast 
present invention. Conventional ultrasonography is useful cancers are cystic in nature, consisting of fluid-filled lesions, 
for examination of a focal region but is neither efficient nor and on the observation by the present inventors that for any 
reproducible from operator to operator or from visit to visit given fluid (characterized in terms of density, ultrasonic 
by the same operator. wave velocity, and viscosity), there exists a characteristic 
Over two decades ago, there was a major effort to assess SO resonance frequency Or frequency range and a threshold 
the value of whole breast screening using automated ultra- ultrasound power level at which cavitation bubbles are 
sonography methodologies. Unfortunately, there were both formed. 
high false-positive and false-negative rates. Nevertheless, These cavitation bubbles are produced during the rarefac- 
later studies demonstrated that ultrasonography can detect, tion phase of the ultrasonic wave, and implode to release 
at least in radiologically dense breasts, cancers not recog- ss shock waves at the pressure phase. The diameter of the 
Recently, one study found by ultrasonography only three ultrasonic emission, and in the range of approximately 500 
cancers per thousand when screening 6113 women with kHz it is on the order of several microns. 
dense breasts and no symptoms and 687 women with The induction of cavitation and the detection of the 
palpable or mammographically detected masses. In com- 60 resulting implosion waves can be carried out transabdomi- 
menting on these studies, Kopans (“Breast Cancer Screening nally and noninvasively through the skin. The location of the 
with Ultrasonography,” Lancet 354 (9196):2096-7 (1999)) cavitation source producing the implosion wave can be 
pointed out that although the independent rate of breast identified and used to create a three-dimensional image of 
cancer detection by ultrasonography alone is not clear, the the cystic fluid structure. The diagnostic procedure accord- 
“possibility of ultrasonography for breast screening should 65 ing to the invention is rapid, with minimum inconvenience 
not be ignored”. The author further noted that handheld to the patient, thus providing an affordable screening tech- 
devices are operator dependent and expensive, requiring nique. 
5 
This application claims the benefit of the filing date of 
provisional application Ser. NO. 601149,901, filed Aug. 23, 
1999. 
GOVERNMENT RIGHTS STATEMENT 
The invention described herein was made with govern- 
ment support under NASA Case No. 20623. The Federal 
Government has certain rights to this invention. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
This invention relates generally to medical diagnostic 2o (MRI), compute tomography (CT) 
imaging, and more particularly to the use of ultrasonic wave 
generation for early detection of cystic structures in the 
body, such as in the breast or ovary, the presence of which 
may indicate the onset of breast cancer or ovarian cancer. 
There thus exists a need for a 
The presence of multiple cysts and fibronodular structures 40 
nized by mammography and physical examination. cavitation bubbles depends upon the wavelength of the 
US 6,406,429 B1 
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In particular, the present invention provides a method for 
identifying the presence of cystic structures in any tissue. A 
first specific application of the invention is as a method for 
recognizing the presence of cystic structures including ova- 
rian cancers in the ovary, The method includes the steps of 
applying ultrasonic wave energy to a patient at a frequency 
causing induction of cavitation in cystic fluid characteristic 
of and other cystic structures in the tissues of 
caused by the implosion of cavitation bubbles formed by the i o  
induction of cavitation, measuring the detected implosion 
waves, and determining the location of the cavitation source 
in the body of the patient. A second specific application of 
the invention is using SINUC to map cystic structures in the 
According to another aspect of the invention, apparatus 
for performing the method of detection of cystic structures 
is provided. 
frequency of 529 kHz. As shown in FIG. 5,  the use of 
continuous ultrasonic waves at high energy cause extensive 
excitation of cavitation and thus increase the temperature to 
a maximum value at the resonance frequency. The location 
of the peak of temperature rise as shown in FIG. 5 coincides 
with a resonant induction of cavitation. Simultaneous mea- 
surement of the wave resulting from implosion of the 
cavitation bubbles, using a hydrophone transducer, showed 
The problem Of wave propagation through tissues can be 
treated as a behavior in viscous fluid, which is described by 
the governing equation: 
5 
humans, such as ovarian tissue, detecting implosion waves a significant increase in amp1itude at the Same frequency. 
radiologically dense breast. 15 
Where: PL is fluid density; V is shear viscosity; VB is bulk 
viscosity; p is pressure; and v is particle velocity. 
To determine the pressure field of the ultrasonic wave, this 
20 equation needs to be solved using appropriate boundary BRIEF DESCRIPTION OF THE DRAWINGS 
conditions. Cavitations are formed when the pressure, p, 
drops below the critical vapor pressure of the fluid, PO. As 
the ultrasonic wave phase changes, the cavitations are 
imploded and their collapse characteristics can be analyzed 
The present invention can be more fully understood from 
the detailed description given below in conjunction with the 
accompanying drawings, These are provided by way of 
illustration only and are not intended as limiting the present 
invention, and wherein: zs using a modified Rayleigh-Plesset equation: 
FIG. 1 A  is a cross sectional view of a patient’s abdomen 
illustrating the placement of an ultrasonic transmitter and 
transducers according to one preferred embodiment of the 
FIG. 1B is an elevational view of the placement of the 
ultrasonic transmitter and transducers of FIG. lA,  
FIG. 2 is a graph illustrating the characteristics of induced 
cavitation bubbles with ultrasonic waves according to the 
invention; 
FIG, 3 is a representative illustration of an image formed 
by implosion waves produced from induced cavitation 
bubbles according to the invention; 
is a block diagram of apparatus for analyzing 
detected cavitation waves to produce images, according to 
the invention; and 
is a graph showing the between 
thermal induction caused by cavitation induced by ultrasonic 
wave and the frequency of the ultrasonic wave. 
l d R  d 2 R  3 1 d R  d R  1 - - - R- + - 1 - - - - = [ c d r )  dr Z[ 3c d r ) [ d r )  
invention; 30 ( 1  + i $ ! ) $ [ P b - P m - P c ( r f  ;)I+-- R R dpb 
fLc  dr 
Where R is the radius of cavitation; c is sound velocity of the 
fluid; Pc, is pressure in the liquid at the location of the 
35 cavitation center in the absence of the cavitation; Po0 is the 
far field pressure; and Pb is internal pressure of the cavita- 
tion. 
The viscosity of the liquid plays an important role in the 
formation of cavitation. The effect of viscosity is to cause 
40 damping and loss of mechanical energy during the growth 
and collapse process. Consequently, it is expected that an 
increase in viscosity will lead to a decrease in maximum 
cavity size and rate of growth and collapse. For liquids with 
different viscosity, the induced impulse level varies although 
45 each is activated by the same acoustic source. Moreover, 
different wave pressure is needed to form a vapor cavity in 
Modeling the cavitation phenomenon requires dealing 
Referring to FIGS. 1A-1B, according to one Preferred with significant nonlinearity and heterogeneity. Nonlineari- 
embodiment, the invention Provides a screening technique SO ties arise from changes in temperature, pressure, stress, 
for early detection of ovarian cancers which utilizes an strain, strain rate, and other properties associated with the 
ultrasonic transmitter 12, and a plurality of receivers 16a, input ultrasonic wave. These changes dynamically affect the 
16b, and 16c. In a preferred configuration, the receivers mechanical and thermal properties of the propagation 
16a-16c are arranged in a tr iandation array in order to medium, altering wave speed and attenuation. Solving par- 
obtain three-dimensional location information of possible 55 tial differential equations with explicit non-linearity is com- 
malignant structures in the ovary. As shown in FIG. lA,  the plicated and tirne consuming, T~ avoid these dificulties, 
transmitter and receivers are Placed on the abdomen of a linear numerical methods are used. To obtain an analytical 
patient 10, at a location opposite from ovary 14. solution to the cavitation problem, incremental linearization 
The screening technique relies upon the induced forma- can be used. For this type of time-dependent problem, 
tion at characteristic resonant frequencies of cavitation 60 ‘‘incrementally linear” means advancing the solution in time 
bubbles in the fluid contained in the cystic structures asso- by discrete increments and modifying the material properties 
ciated with ovarian cancer. The induced cavitation forms at the end of each increment. Time increments must be small 
implosion waves having a spectral content that is relatively enough that the solution is linear Over each increment. Using 
easy to measure and to use to identify the location of the this approach the response of cavitation can be determined 
cavitation source. 65 and the effect of various related parameters can be incorpo- 
Experiments by the present inventors have shown that in rated. A computer simulation can be developed to examine 
water, a resonant response wave can be obtained at a the effect of changing liquid properties and input wave 
FIG, 
DETAILED DESCRIPTION OF THE 
PREFERRED EMBODIMENTS different liquids. 
US 6,406,429 B3 
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parameters on the induction of cavitation and emission of 
impulses. The frequency of the input wave can be optimized 
to produce small cavitation for high sensitivity of detection 
while accounting for the increased attenuation. 
The transabdominal sonography using the transmitter as 
shown in FIGS. 1A-1B thus can selectively induce cavita- 
tion in the cystic fluids of the ovary, which in turn produces 
singularly detectable and identifiable implosion waves. 
Ultrasound energy is produced at energy levels and dura- 
tions that does not result in tissue damage. The signals 
received by the transducers or receivers 16a-16c are used to 
create a three-dimensional image of ovarian cystic struc- 
tures. The location of the cyst can be determined using 
well-established acoustic emission non-destructive testing 
method technology. 
FIG. 2 shows the relationship between the wavelength, 
phase and cavitation diameter, at a frequency of approxi- 
mately 25 kHz. As shown, this results in the inducement of 
a cavitation bubble of approximately 45 microns in radius. 
Using a frequency on the order of several hundreds of 
kilohertz would lead to the induction of cavitation bubbles 
in the range of several microns. The particular resonance 
frequency for inducing cavitation in cystic fluid conditions 
representing human ovarian cysts can be identified by sub- 
jecting female patients to ultrasonic waves at various fre- 
quencies to identify the resonant frequency that uniquely 
identifies the ovarian cystic fluid. As stated above, in water 
this condition occurs at 529 kHz. FIG. 3 is an illustration 
showing the general character of cavitation bubbles induced 
by a focused ultrasonic transducer 12 using a continuous 
wave. 
In practice, as shown in FIG. 4, the signals from receiver 
transducers 16a-16c are inputted to a processor 40, such as 
a PC, workstation, or other computer, and are processed in 
conjunction with a triangulation algorithm to obtain a three 
dimensional image of the cystic structure(s) and its location. 
As shown in FIGS. 1A-lB, a number of receiving trans- 
ducers are placed at preselected locations on the patient’s 
abdomen, proximate the plane of the ovary 14. The received 
signals are analyzed and processed to determine the three- 
dimensional distribution of cavitation source sites. The 
control parameters of the ultrasonic waves (including pulse 
rate, duration, amplitude and center frequency) are deter- 
mined in advance through experimentation, and are selected 
to ensure that no damage to tissue or to internal organs 
results from the application of ultrasonic energy. To ensure 
that the ultrasonic wave does not produce a significant 
temperature rise in the patient’s tissues, short pulses on the 
order of milliseconds or shorter are used. The control 
parameters are selected to enable the ultrasonic waves to 
reach the cavitation excitation threshold level and to selec- 
tively induce cavitation in cystic fluid in a manner that 
maximizes screening sensitivity. Suitable in vivo experi- 
mentation can be carried out using artificial cysts of known 
density in order to identify the values of such control 
parameters. The identification of a unique resonance fre- 
quency for the induction of cavitation in ovarian cysts with 
minimum excitation in surrounding tissues and organs thus 
enables the early detection of ovarian cancers at sizes on the 
order of several microns, thereby significantly increasing the 
chances for cure by medical intervention at an early stage. 
The novel method of the present invention offers a highly 
sensitive, rapid, non-invasive screening method for patients 
at high risk for ovarian cancer, and for tracking changes in 
the size and structures of known abnormalities. A follow-up 
transvaginal sonography test can be made for detailed evalu- 
ation when the ultrasonic screening method of the invention 
indicates the presence of a potential malignancy. 
6 
A similar transmitter-receiver configuration can be imple- 
mented for whole breast scanning. 
The method of the present invention also can be used to 
identify the presence of cystic structures in any human 
s tissue, in addition to ovarian tissue and breast tissue, and 
therefore may be used in other diagnostic procedures to 
identify such structures. 
The invention having been thus described, it be apparent 
to those skilled in the art that the same may be varied in 
i o  many ways without departing from the spirit and scope of 
the invention. Accordingly, any and all such modifications 
are intended to be covered by the following claims. 
What is claimed is: 
1 .  A method for identifying cystic structures in human 
applying ultrasonic wave energy to a patient at a fre- 
quency causing induction of cavitation in cystic fluid 
characteristic of cystic structures in human tissue; 
detecting implosion waves caused by the implosion of 
cavitation bubbles formed by said induction of cavita- 
tion; 
measuring the detected implosion waves to detect the 
existence of a cystic structure; and determining the 
location of the cavitation source in the body of the 
patient from the measured implosion waves. 
2. The method of claim 1, wherein the method is used to 
identify cystic structures in the ovary of a patient, and the 
step of applying comprises the step of attaching an ultra- 
3o sonic wave generating transducer to the abdomen of the 
patient, in the plane of an ovary of the patient. 
3. The method of claim 2, wherein the step of detecting 
comprises the step of attaching at least one ultrasonic 
receiving transducer to the abdomen of the patient in the 
4. The method of claim 3, wherein the step of detecting 
further comprises the step of attaching a second and third 
ultrasonic receiving transducer to the abdomen of the 
patient, one of said second and third receiving transducers 
4o being located above the plane of said ovary and the other 
being located in the plane of said ovary together with said 
first receiving transducer. 
5 .  The method of claim 1,  wherein the frequency of said 
ultrasonic wave energy is on the order of hundreds of 
kilo hertz. 
6. The method of claim 1, wherein the method is used to 
identify cystic structures in the breast of a patient, and the 
step of applying comprises the step of attaching an ultra- 
sonic wave generating transducer to the breast of the patient. 
7. The method of claim 6, wherein the step of detecting 
comprises the step of attaching at least one ultrasonic 
receiving transducer to the breast of the patient. 
8. Apparatus for identifying cystic i n tissue, comprising: 
an ultrasonic wave generator that applies ultrasonic wave 
energy to a patient at a frequency causing induction of 
cavitation in cystic fluid characteristic of cystic struc- 
tures in human tissue; 
at least one ultrasonic wave receiver that detects implo- 
sion waves caused by the implosion of cavitation 
bubbles formed by said induction of cavitation; 
a signal processor measuring the detected implosion 
waves to detect the existence of a cystic structure, and 
for determining the location of the cavitation source in 
the body of the patient from the measured implosion 
9. Apparatus according to claim 8, wherein said cystic 
structures are present in the human ovary, and are indicative 
is tissue, comprising the steps of  
2o 
2s 
3s plane of said ovary. 
4s 
so 
ss 
60 
65 waves. 
US 6,406,429 B1 
7 8 
of the presence of ovarian cancer, and wherein said ultra- 
sonic wave generator comprises an ultrasonic wave gener- 
ating transducer attachable to the abdomen of the patient, in 
the plane of an ovary of the patient. 
one ultrasonic wave receiver comprises a receiving trans- 
ducer attachable to the abdomen of the patient in the plane 
of said ovary. 
11. Apparatus according to claim 10, further comprising 
second and third ultrasonic receiving transducers attachable i o  
to the abdomen of the patient, one of said second and third 
receiving transducers being located above the plane of said 
ovary and the other being located in the plane of said ovary 
12. Apparatus according to claim 8, wherein the fre- 
quency of said ultrasonic wave energy is on the order of 
hundreds of kilohertz, 
13. Apparatus according to claim 8, wherein said cystic 
of the presence of breast cancer, and wherein said ultrasonic 
wave generator comprises an ultrasonic wave generating 
14. Apparatus according to claim 13, wherein said at least 
one ultrasonic wave receiver comprises a receiving trans- 
ducer attachable to the breast of the patient. 
lo. Apparatus according to 9, wherein said at least stmctures are present in the human breast, and are indicative 
transducer to the breast Of the patient. 
together with said first receiving transducer. * * * * *  
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